![](/img/cover-not-exists.png)
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
Wen, P. Y., Yung, W.K. A., Lamborn, K. R., Norden, A. D., Cloughesy, T. F., Abrey, L. E., Fine, H. A., Chang, S. M., Robins, H. I., Fink, K., DeAngelis, L. M., Mehta, M., Di Tomaso, E., Drappatz, J.,Volume:
11
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1215/15228517-2009-010
Date:
January, 2009
File:
PDF, 4.57 MB
english, 2009